Dr. Frank Gredler, M.D.
What this data tells you about Dr. Gredler
Dr. Frank Gredler is a cardiovascular disease in Tallahassee, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gredler performed 4,050 Medicare services across 2,943 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gredler received a total of $16,016 from 24 pharmaceutical and/or device companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gredler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 766 | $6 | $63 |
| Office visit, established patient (30-39 min) | 603 | $87 | $205 |
| Electrocardiogram (EKG), 12-lead | 390 | $10 | $53 |
| Regadenoson injection (Lexiscan) for heart stress test | 382 | $44 | $210 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 351 | $88 | $231 |
| Echocardiogram, transthoracic | 253 | $134 | $474 |
| Anticoagulant management of patient taking warfarin | 185 | $8 | $21 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 176 | $326 | $733 |
| Prothrombin time test (blood clotting) | 171 | $4 | $17 |
| Office visit, established patient (20-29 min) | 150 | $60 | $152 |
| Ultrasound of both sides of head and neck blood flow | 107 | $138 | $305 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 101 | $46 | $189 |
| Hospital follow-up visit, moderate complexity | 70 | $59 | $116 |
| New patient office visit (45-59 min) | 68 | $127 | $273 |
| Hospital follow-up visit, low complexity | 35 | $38 | $95 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $80 | $200 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $2 | $289 |
| Initial hospital admission, high complexity | 26 | $137 | $318 |
| Heart muscle strain imaging | 25 | $27 | $63 |
| Initial hospital admission, moderate complexity | 21 | $102 | $228 |
| Injection, aminophyllin, up to 250 mg | 18 | $1 | $1 |
| External shock to heart to regulate heart beat | 17 | $77 | $378 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $14 | $95 |
| Electrocardiogram (ecg) 2-day continuous | 14 | $13 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $14 | $42 |
| Ultrasound study of arm and leg arteries | 13 | $61 | $168 |
| Office visit, established patient, complex (40-54 min) | 11 | $127 | $289 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gredler is a clinical cardiology specialist, with above-average Medicare volume (top 28% in FL), and high industry engagement (speaking/promotional, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gredler experienced with ekg interpretation and report?
Does Dr. Gredler receive payments from pharmaceutical companies?
How do Dr. Gredler's costs compare to other cardiovascular diseases in Tallahassee?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology